Joseph Kofi Agyin, Ph.D., M.B.A., is an Assistant Professor of Chemistry at the University of Texas Health Science Center at San Antonio, Texas. There he is studying the design and synthesis of bone-targeted proteasome inhibitors for treating multiple myeloma, a blood cancer that develops in the bone marrow.
The incidence of multiple myeloma is twice as high in African Americans compared with the white population. There is currently no cure for multiple myeloma but there are several promising new therapies. Multiple myeloma causes bone destruction, and depending on the location of the cancer, also causes injury to surrounding tissues.